Myopia progression patterns among paediatric patients in a clinical setting

Michael Moore1, Gareth Lingham1,2, Daniel I Flitcroft1,3

  • 1Centre for Eye Research Ireland, School of Physics, Clinical and Optometric Sciences, Technological University Dublin, Dublin, Ireland.

Insights

This study analyzed untreated myopia progression in children aged 7-17. Progression was fastest in younger children and slowed with age, informing future myopia management strategies.

Area of Science:

  • Ophthalmology
  • Pediatric Optometry
  • Myopia Research

Background:

  • Myopic progression in children is a growing concern globally.
  • Understanding the natural history of untreated myopia is crucial for effective management.
  • Existing data on myopia progression rates in children often lack real-world, diverse patient populations.

Purpose of the Study:

  • To investigate the natural history of myopic progression in children using electronic medical record (EMR) data from Irish optometric practices.
  • To establish age- and sex-specific population centiles for annual myopic progression in untreated children.
  • To compare observed progression rates with data from randomized clinical trials (RCTs) and predictive models.

Main Methods:

  • Retrospective analysis of EMR data from myopic patients aged 7-17 without myopia control treatment.
  • Derivation of population centiles for annual myopic progression using weighted cubic splines.
  • Comparison with RCT control group data and analysis using linear mixed models (LMMs) and survival analysis.

Main Results:

  • Myopia progression was highest at age 7 (median: -0.67 D/year) and slowed with age (median: -0.18 D/year at age 17).
  • Faster progression was predicted by female sex, higher baseline myopia, and younger age.
  • RCT control groups showed higher mean progression than observed EMR data; clinic-based studies aligned more closely.

Conclusions:

  • The study provides valuable progression centiles for untreated myopic children, defining the natural history of myopia.
  • These findings will aid clinicians in predicting refractive outcomes without treatment.
  • The data will also support monitoring treatment efficacy, especially when axial length data is unavailable.
Abstract